No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Empyema Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat empyema, a condition in which pus accumulates in the pleural cavity. These drugs are typically antibiotics, and may be administered orally, intravenously, or through inhalation. They are used to reduce inflammation, reduce the amount of pus, and prevent further infection.
The Empyema Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Sanofi, AstraZeneca, and Novartis. Other companies, such as Allergan, Boehringer Ingelheim, and Daiichi Sankyo, also offer treatments for empyema. Show Less Read more
